Cephalexin for Oral Suspension, USP 250 mg per 5 mL, 100 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88
Published February 24, 2021 · Recall initiated: January 22, 2021
Summary
FDA records drug Class II recall D-0263-2021, published February 24, 2021 and initiated January 22, 2021. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 14,205 100 mL bottles; Lot: Lot # 19144841, Exp 9/2021; 20141673 Exp 4/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if CEPHALEXIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEPHALEXIN
- Manufacturer
- Ascend Laboratories LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot # 19144841, Exp 9/2021; 20141673 Exp 4/2022.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx Only, Manufactured by: AlkemJune 18, 2025
- FDACephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: AlkemJune 18, 2025
- FDACephalexin for Oral Suspension, USP, 250mg per 5mL, Rx only, 100mL (when mixed), Each contains cephalexinJune 12, 2024
- FDACephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 200mL (when mixed), Each contains: cephalexinJune 12, 2024
- FDAAuryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by:February 24, 2021
- FDACephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: AlkemFebruary 24, 2021
Questions about this recall
Was Cephalexin for Oral Suspension, USP 250 mg per 5 mL, 100 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88 recalled?
Yes. FDA published recall D-0263-2021 on February 24, 2021. Reported hazard: CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEPHALEXIN.